酵素伤口清创市场规模、份额和趋势分析报告：2023-2030 年按类型、产品、最终用途、地区和细分市场进行的预测

Enzymatic Wound Debridement Market Size, Share & Trends Analysis Report By Type, By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2030

出版日期: 2023年12月07日 | 出版商:

Grand View Research | 英文 79 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

酵素伤口清创市场成长与趋势：

根据Grand View Research, Inc.最新报告，到2030年，全球酵素法伤口清创市场规模预计将达到13.918亿美元，预测期内复合年增长率为6.2%。

技术先进产品的推出和慢性病盛行率的上升是推动成长的一些主要因素。

全球对酵素伤口清创产品的需求不断增长，促使研究人员和主要企业采取各种措施并开发技术先进的产品，预计将推动市场成长。迄今为止，基于胶原蛋白酶的酵素伤口去除产品主要用于治疗慢性和急性伤口，基于木瓜蛋白酶的产品主要用于治疗慢性伤口。由于人们对此类产品的使用意识不断增强，一些技术先进的产品已被引入市场。例如，Nexobrid (NXB)，以前称为清创凝胶敷料 (DGD)，源自凤梨凤梨蛋白酶家族，于 2017 年推出。 NXB是一种酵素伤口清创剂，可有效用于治疗深度烧伤创面。

该产品最近获得核准，市场参与者正在努力推出该产品，作为其创伤护理产品系列的一部分。例如，2019年5月，Vericel Corporation与MediWound Ltd.签订了供应协议并获得在北美商业化的独家许可。该产品也获得了欧盟、美国等国际市场的核准。因此，此类倡议预计将对预测期内的成长产生正面影响。

酵素法伤口清创市场报告亮点

从销售额来看，由于外伤病例增加，2022年急性伤口领域占最大份额。
由于患有慢性伤口的老年人口不断增加，并且更喜欢居家照护而不是住院治疗，预计居家照护行业在预测期内将出现最快的增长。
由于慢性伤口的增加，胶原蛋白酶产品领域在 2022 年占据最大份额。
由于糖尿病患者人数不断增加，预计亚太地区在预测期内将出现最快的增长。

区域展望
酵素伤口清创市场，按地区：要点
北美洲
- 2018-2030 年市场估计与预测
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 法国
- 义大利
- 西班牙
- 瑞典
- 挪威
- 丹麦
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 泰国
- 韩国
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中东/非洲
- 沙乌地阿拉伯
- 南非
- 阿拉伯聯合大公国
- 科威特

第八章竞争形势

主要市场参与企业的最新趋势和影响分析
公司/竞争分类
- Convatec Inc.
- Smith & Nephew
- Molnlycke Health Care AB
- Integra LifeSciences
- SOLASCURE Limited
- B. Braun

简介目录图表

Product Code: GVR-3-68038-259-4

Enzymatic Wound Debridement Market Growth & Trends:

The global enzymatic wound debridement market size is expected to reach USD 1,391.8 million by 2030, according to a new report by Grand View Research, Inc., exhibiting a 6.2% CAGR during the forecast period. Introduction of technologically advanced products and rise in incidence of chronic diseases are some of the key factors aiding growth.

Various initiatives are being undertaken by researchers and key players are developing technologically advanced products owing to rising demand for enzymatic wound debridement products globally, which is anticipated to boost market growth. Until now, collagenase-based enzymatic wound debridement products have been majorly used for treatment of chronic & acute wounds and papain-based products have been predominantly used for treatment of chronic wounds. Since awareness about the use of such products is increasing, several technologically advanced products are being introduced in the market. For instance, NexoBrid (NXB), previously referred to as Debriding Gel Dressing (DGD)-which is derived from pineapple Bromelain group of enzymes-was introduced in 2017. NXB is an enzymatic wound debriding drug that can be effectively used in treating deep burn wounds.

The product recently received approval and market players are undertaking initiatives to launch this product under their wound care product portfolio. For instance, in May 2019, Vericel Corporation entered into a supply agreement and exclusive license with MediWound Ltd. with an aim to commercialize the product in North America. The product also received approval in European Union, the U.S., and other international markets. Therefore, such initiatives are anticipated to positively impact growth over the forecast period.

Enzymatic Wound Debridement Market Report Highlights:

In terms of revenue, acute wounds segment held the largest share in 2022 owing to rising trauma cases
Homecare segment is expected to witness fastest growth rate over the forecast period owing to increasing geriatric population suffering from chronic wounds, who prefer homecare over hospital stay
Collagenase product segment held the largest share in 2022 due to rising incidence of chronic wounds
Asia Pacific is expected to witness fastest growth over the forecast period owing to rising number diabetic patients in this region

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. Product
- 1.1.3. End Use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
- 1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Product outlook
- 2.2.3. End use outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Industry Outlook

3.1. Market Segmentation
3.2. Market Variable Analysis
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
  - 3.2.2.1 Stringent regulatory policies
3.3. Penetration & Growth Prospect Mapping
3.4. Business Environment Analysis tools
- 3.4.1. SWOT Analysis, by PEST
- 3.4.2. Porter's five forces analysis

Chapter 4. Enzymatic Wound Debridement Market: Type Estimates & Trend Analysis

4.1. Enzymatic Wound Debridement Market: Key Takeaways
4.2. Enzymatic Wound Debridement Market: Type Movement & Market Share Analysis, 2022 & 2030
4.3. Chronic wounds
- 4.3.1. Chronic wounds market estimates and forecast 2022 to 2030 (USD Million)
  - 4.3.1.1. Diabetic Foot Ulcers
  - 4.3.1.1.1. Diabetic foot ulcers market estimates and forecast 2022 to 2030 (USD Million)
  - 4.3.1.2. Pressure Ulcers
  - 4.3.1.2.1. Pressure ulcers market estimates and forecast 2022 to 2030 (USD Million)
  - 4.3.1.3. Venous Leg Ulcers
  - 4.3.1.3.1. Venous leg ulcers market estimates and forecast 2022 to 2030 (USD Million)
4.4. Acute Wounds
- 4.4.1. Acute wounds market estimates and forecast 2022 to 2030 (USD Million)
  - 4.4.1.1. Burns
  - 4.4.1.1.1. Burns market estimates and forecast 2022 to 2030 (USD Million)
  - 4.4.1.2. Other Acute Wounds
  - 4.4.1.2.1. Other acute wounds market estimates and forecast 2022 to 2030 (USD Million)

Chapter 5. Enzymatic Wound Debridement Market: Product Estimates & Trend Analysis

5.1. Enzymatic Wound Debridement Market: Key Takeaways
5.2. Enzymatic Wound Debridement Market: Product Movement & Market Share Analysis, 2022 & 2030
5.3. Collagenase Product
- 5.3.1. Collagenase Product market estimates and forecasts, 2022 to 2030 (USD Million)
5.4. Papain Product
- 5.4.1. Papain Product market estimates and forecasts, 2022 to 2030 (USD Million)
5.5. Others
- 5.5.1. Others market estimates and forecasts, 2022 to 2030 (USD Million)

Chapter 6. Enzymatic Wound Debridement Market: End-use Estimates & Trend Analysis

6.1. Enzymatic Wound Debridement Market: Key Takeaways
6.2. Enzymatic Wound Debridement Market: End-use Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
- 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Homecare
- 6.4.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Others
- 6.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Enzymatic Wound Debridement Market: Regional Estimates & Trend Analysis

7.1. Regional Outlook
7.2. Enzymatic Wound Debridement Market, by Region: Key Takeaways
7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.3. Canada
  - 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
- 7.4.1. UK
  - 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. Germany
  - 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. France
  - 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Italy
  - 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.5. Spain
  - 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.6. Sweden
  - 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.7. Norway
  - 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.8. Denmark
  - 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
- 7.5.1. Japan
  - 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. China
  - 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.3. India
  - 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.4. Australia
  - 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.5. Thailand
  - 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.6. South Korea
  - 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
- 7.6.1. Brazil
  - 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. Mexico
  - 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
- 7.7.1. Saudi Arabia
  - 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. South Africa
  - 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. UAE
  - 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.4. Kuwait
  - 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
- 8.2.1. Convatec Inc.
  - 8.2.1.1. Company overview
  - 8.2.1.2. Financial performance
  - 8.2.1.3. Product benchmarking
  - 8.2.1.4. Strategic initiatives
- 8.2.2. Smith & Nephew
  - 8.2.2.1. Company overview
  - 8.2.2.2. Financial performance
  - 8.2.2.3. Product benchmarking
  - 8.2.2.4. Strategic initiatives
- 8.2.3. Molnlycke Health Care AB
  - 8.2.3.1. Company overview
  - 8.2.3.2. Financial performance
  - 8.2.3.3. Product benchmarking
  - 8.2.3.4. Strategic initiatives
- 8.2.4. Integra LifeSciences
  - 8.2.4.1. Company overview
  - 8.2.4.2. Financial performance
  - 8.2.4.3. Product benchmarking
  - 8.2.4.4. Strategic initiatives
- 8.2.5. SOLASCURE Limited
  - 8.2.5.1. Company overview
  - 8.2.5.2. Financial performance
  - 8.2.5.3. Product benchmarking
  - 8.2.5.4. Strategic initiatives
- 8.2.6. B. Braun
  - 8.2.6.1. Company overview
  - 8.2.6.2. Financial performance
  - 8.2.6.3. Product benchmarking
  - 8.2.6.4. Strategic initiatives

简介目录图表

List of Tables

Table 1 List of Abbreviations
Table 2 North America enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 3 North America enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 4 North America enzymatic wound debridement market, by end use, (USD Million) 2018 -2030
Table 5 North America enzymatic wound debridement market, by country, 2018 - 2030 (USD Million)
Table 6 U.S. enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 7 U.S. enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 8 U.S. enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 9 Canada enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 10 Canada enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 11 Canada enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 12 Europe enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 13 Europe enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 14 Europe enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 15 Europe enzymatic wound debridement market, by country, 2018 - 2030 (USD Million)
Table 16 Germany enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 17 Germany enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 18 Germany enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 19 UK enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 20 UK enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 21 UK enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 22 France enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 23 France enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 24 France enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 25 Italy enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 26 Italy enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 27 Italy enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 28 Spain enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 29 Spain enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 30 Spain enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 31 Sweden enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 32 Sweden enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 33 Sweden enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 34 Norway enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 35 Norway enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 36 Norway enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 37 Denmark enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 38 Denmark enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 39 Denmark enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 41 Asia Pacific enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 42 Asia Pacific enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 43 Asia Pacific enzymatic wound debridement market, by country, 2018 - 2030 (USD Million)
Table 44 China enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 45 China enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 46 China enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 47 Japan enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 48 Japan enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 49 Japan enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 50 India enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 51 India enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 52 India enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 53 Australia enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 54 Australia enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 55 Australia enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 56 Thailand enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 57 Thailand enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 58 Thailand enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 59 South Korea enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 60 South Korea enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 61 South Korea enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 62 Latin America enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 63 Latin America enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 64 Latin America enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 65 Latin America enzymatic wound debridement market, by country, 2018 - 2030 (USD Million)
Table 66 Brazil enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 67 Brazil enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 68 Brazil enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 69 Mexico enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 70 Mexico enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 71 Mexico enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 72 Argentina enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 73 Argentina enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 74 Argentina enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa enzymatic wound debridement market, by type, (USD Million) 2018-2030
Table 76 Middle East and Africa enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa enzymatic wound debridement market, by country, 2018 - 2030 (USD Million)
Table 79 South Africa enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 80 South Africa enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 81 South Africa enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 85 UAE enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 86 UAE enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 87 UAE enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)
Table 88 Kuwait enzymatic wound debridement market, by type, 2018 - 2030 (USD Million)
Table 89 Kuwait enzymatic wound debridement market, by product, 2018 - 2030 (USD Million)
Table 90 Kuwait enzymatic wound debridement market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market summary
Fig. 9 Enzymatic wound debridement market segmentation
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Penetration & growth prospect mapping
Fig. 13 SWOT analysis, by a factor (political & legal, economic and technological)
Fig. 14 Porter's five forces analysis
Fig. 15 Enzymatic wound debridement market product outlook: Key takeaways
Fig. 16 Enzymatic wound debridement market: Product movement analysis
Fig. 17 Collagenase product market, 2018 - 2030 (USD Million)
Fig. 18 Papain product market, 2018 - 2030 (USD Million)
Fig. 19 Other enzymatic wound debridement product market, 2018 - 2030 (USD Million)
Fig. 20 Enzymatic wound debridement market type outlook: Key takeaways
Fig. 21 Enzymatic wound debridement market: Type movement analysis
Fig. 22 Chronic wounds market, 2018 - 2030 (USD Million)
Fig. 23 Diabetic foot ulcers market, 2018 - 2030 (USD Million)
Fig. 24 Pressure ulcers market, 2018 - 2030 (USD Million)
Fig. 25 Venous leg ulcers market, 2018 - 2030 (USD Million)
Fig. 26 Acute wounds market, 2018 - 2030 (USD Million)
Fig. 27 Burn wounds market, 2018 - 2030 (USD Million)
Fig. 28 Other acute wounds market, 2018 - 2030 (USD Million)
Fig. 29 Enzymatic wound debridement market end-use outlook: Key takeaways
Fig. 30 Enzymatic wound debridement market: End-use movement analysis
Fig. 31 Hospitals market, 2018 - 2030 (USD Million)
Fig. 32 Homecare market, 2018 - 2030 (USD Million)
Fig. 33 Others market, 2018 - 2030 (USD Million)
Fig. 34 North America market estimates and forecasts, 2018 - 2030
Fig. 35 U.S. market estimates and forecasts, 2018 - 2030
Fig. 36 Canada market estimates and forecasts, 2018 - 2030
Fig. 37 Europe market estimates and forecasts, 2018 - 2030
Fig. 38 UK market estimates and forecasts, 2018 - 2030
Fig. 39 Germany market estimates and forecasts, 2018 - 2030
Fig. 40 France market estimates and forecasts, 2018 - 2030
Fig. 41 Italy market estimates and forecasts, 2018 - 2030
Fig. 42 Spain market estimates and forecasts, 2018 - 2030
Fig. 43 Sweden market estimates and forecasts, 2018 - 2030
Fig. 44 Norway market estimates and forecasts, 2018 - 2030
Fig. 45 Denmark market estimates and forecasts, 2018 - 2030
Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 47 Japan market estimates and forecasts, 2018 - 2030
Fig. 48 China market estimates and forecasts, 2018 - 2030
Fig. 49 India market estimates and forecasts, 2018 - 2030
Fig. 50 Australia market estimates and forecasts, 2018 - 2030
Fig. 51 Thailand market estimates and forecasts, 2018 - 2030
Fig. 52 South Korea market estimates and forecasts, 2018 - 2030
Fig. 53 Latin America market estimates and forecasts, 2018 - 2030
Fig. 54 Brazil market estimates and forecasts, 2018 - 2030
Fig. 55 Mexico market estimates and forecasts, 2018 - 2030
Fig. 56 Argentina market estimates and forecasts, 2018 - 2030
Fig. 57 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 59 South Africa market estimates and forecasts, 2018 - 2030
Fig. 60 UAE market estimates and forecasts, 2018 - 2030
Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030